Works by Mathew, Paul


Results: 109
    1
    2
    3
    4
    5
    6
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33

    Cleanroom Energy Efficiency.

    Published in:
    ASHRAE Journal, 2010, v. 52, n. 10, p. 24
    By:
    • Mathew, Paul A.;
    • Tschudi, William;
    • Sartor, Dale;
    • Beasley, James
    Publication type:
    Article
    34

    Metrics for Energy Efficiency.

    Published in:
    ASHRAE Journal, 2008, v. 50, n. 4, p. 40
    By:
    • Mathew, Paul;
    • Greenberg, Steve;
    • Dale Sartor;
    • Rumsey, Peter;
    • Weale, John
    Publication type:
    Article
    35

    Rapid and sustained decline in CXCL-10 (IP-10) annotates clinical outcomes following TNFα-antagonist therapy in hospitalized patients with severe and critical COVID-19 respiratory failure.

    Published in:
    Journal of Clinical & Translational Science, 2021, v. 5, n. 1, p. 1, doi. 10.1017/cts.2021.805
    By:
    • Hachem, Hilal;
    • Godara, Amandeep;
    • Schroeder, Courtney;
    • Fein, Daniel;
    • Mann, Hashim;
    • Lawlor, Christian;
    • Marshall, Jill;
    • Klein, Andreas;
    • Poutsiaka, Debra;
    • Breeze, Janis L.;
    • Joshi, Raghav;
    • Mathew, Paul
    Publication type:
    Article
    36
    37
    38
    39
    40

    Active Surveillance in Men With Localized Prostate Cancer.

    Published in:
    Annals of Internal Medicine, 2012, v. 156, n. 8, p. 582, doi. 10.7326/0003-4819-156-8-201204170-00009
    By:
    • Dahabreh, Issa J.;
    • Chung, Mei;
    • Balk, Ethan M.;
    • Yu, Winifred W.;
    • Mathew, Paul;
    • Lau, Joseph;
    • Ip, Stanley
    Publication type:
    Article
    41
    42
    43

    Erratum to: Cilengitide (EMD 121974, NSC 707544) in asymptomatic metastatic castration resistant prostate cancer patients: a randomized phase II trial by the prostate cancer clinical trials consortium.

    Published in:
    2011
    By:
    • Bradley, Deborah;
    • Daignault, Stephanie;
    • Ryan, Charles;
    • DiPaola, Robert;
    • Cooney, Kathleen;
    • Smith, David;
    • Small, Eric;
    • Mathew, Paul;
    • Gross, Mitchell;
    • Stein, Mark;
    • Chen, Alice;
    • Pienta, Kenneth;
    • Escara-Wilke, June;
    • Doyle, Gerald;
    • Al-Hawary, Mahmoud;
    • Keller, Evan;
    • Hussain, Maha
    Publication type:
    Correction Notice
    44
    45
    46
    47
    48
    49
    50

    Dasatinib combined with docetaxel for castration-resistant prostate cancer.

    Published in:
    Cancer (0008543X), 2012, v. 118, n. 1, p. 63, doi. 10.1002/cncr.26204
    By:
    • Araujo, John C.;
    • Mathew, Paul;
    • Armstrong, Andrew J.;
    • Braud, Edward L.;
    • Posadas, Edwin;
    • Lonberg, Mathew;
    • Gallick, Gary E.;
    • Trudel, Géralyn C.;
    • Paliwal, Prashni;
    • Agrawal, Shruti;
    • Logothetis, Christopher J.
    Publication type:
    Article